Common Contracts
2 similar Securities Purchase Agreement contracts by Autolus Therapeutics PLC
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 8th, 2024 • Autolus Therapeutics PLC • Biological products, (no disgnostic substances) • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of February 6, 2024 by and among AUTOLUS THERAPEUTICS PLC (registered number 11185179), a public limited company incorporated in England and Wales whose registered office is at The MediaWorks, 191 Wood Lane, London W12 7FP, United Kingdom (the “Company”), and BioNTech SE, a Societas Europaea organized and existing under the laws of Germany (the “Investor”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 8th, 2021 • Autolus Therapeutics PLC • Biological products, (no disgnostic substances) • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 6, 2021 by and among AUTOLUS THERAPEUTICS PLC (registered number 11185179), a public limited company incorporated in England and Wales whose registered office is at The MediaWorks, 191 Wood Lane, London W12 7FP, United Kingdom (the “Company”), and BXLS V – AUTOBAHN L.P. (“Blackstone” or the “Investor”).
